The expanding landscape of the glucagon signaling network: mechanisms and outcomes
Endocrinology · 2026
DOI: 10.1210/endocr/bqag041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, 2026. Verfasst von Ashish Foollee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrient Metabolism & Signalling Laboratory, Metabolism, Diabetes and Obesity Program, Monash Biomedicine Discovery Institute, Monash University, Cla…. Hauptthemen laut MEDLINE: Signal Transduction, Glucagon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHMRC, Millennium Award for T2D from Diabetes Australia, Faculty Early Career Postdoctoral Fellowships.
Abstract (Originalsprache)
Glucagon is a peptide hormone mainly secreted by the alpha cells of the pancreatic islets in response to nutritional stimuli. Traditionally recognized for its hyperglycemic function counteracting insulin action, it mainly acts on the liver to affect glycogen, amino acid, lipid, and energy metabolism. Beyond its metabolic effects, glucagon also increases hepatocyte cell survival and reduces viral replication. Peptides with glucagon activity have recently emerged as a promising therapeutic candidate for obesity, type 2 diabetes, and associated liver disease, with several glucagon-based agents currently in phase 2/3 clinical trials. Despite this progression, and although discovered roughly the same time as insulin, how glucagon exerts its pleiotropic effects on metabolism and beyond remains relatively poorly understood. Knowledge of these signaling pathways could pave the way for further refinement of glucagon-based pharmacotherapy with more pronounced effects or reduced side effects. This review aims to address established literature and its limitations on glucagon signaling mechanisms and provides an update on the state of the art on glucagon signaling pathways to help in understanding the mechanisms behind glucagon action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrient Metabolism & Signalling Laboratory, Metabolism, Diabetes and Obesity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
- Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Clayton, Victoria 3800, Australia.
ORCID-Profile: Adam J Rose
Förderung
- NHMRC
- Millennium Award for T2D from Diabetes Australia
- Faculty Early Career Postdoctoral Fellowships
- Monash Medicine Nursing and Health Sciences
- Monash University
Zitieren
APA
Foollee, A., Wu, Y., Rusu, P. M., & Rose, A. J. (2026). The expanding landscape of the glucagon signaling network: mechanisms and outcomes. Endocrinology. https://doi.org/10.1210/endocr/bqag041
Vancouver
Foollee A, Wu Y, Rusu PM, Rose AJ. The expanding landscape of the glucagon signaling network: mechanisms and outcomes. Endocrinology. 2026. doi:10.1210/endocr/bqag041
BibTeX
@article{Foollee2026,
author = {Foollee, Ashish and Wu, Yuqin and Rusu, Patricia M and Rose, Adam J},
title = {The expanding landscape of the glucagon signaling network: mechanisms and outcomes},
journal = {Endocrinology},
year = {2026},
doi = {10.1210/endocr/bqag041}
}
EUVIMED